about
Infections caused by Scedosporium spp.Molecular Phylogeny of the Pseudallescheria boydii Species Complex: Proposal of Two New SpeciesScedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*Characterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functionsPrevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.Combination treatment of invasive fungal infections.Treatment of scedosporiosis with voriconazole: clinical experience with 107 patientsMolecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.Scedosporium prolificans: an emerging pathogen in France?Invasive mold infections: recent advances in management approaches.Emerging moulds: epidemiological trends and antifungal resistance.Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment.Bone and joint infections by Mucorales, Scedosporium, Fusarium and even rarer fungi.Scedosporium prolificans osteomyelitis following penetrating injury: A case report.Infective endocarditis caused by Scedosporium prolificans infection in a patient with acute myeloid leukemia undergoing induction chemotherapy.Management of Scedosporium apiospermum in a pre- and post-lung transplant patient with cystic fibrosis.Antifungal effects of palmitic acid salt and ultrapure soft water on Scedosporium apiospermum.Scedosporium apiospermum peritonitis in a patient undergoing peritoneal dialysis.Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine.Molecular identification and in vitro antifungal susceptibility of Scedosporium complex isolates from high-human-activity sites in Mexico.
P2860
Q24657691-6888E08A-DB35-4300-BE3C-D5212750522EQ28315329-0E6B8B2A-43C6-42E3-8D4B-A6489FF8BFEBQ28315344-A830114E-C095-479C-849C-9325C0055D2FQ28539197-E43290D5-095A-4953-B9C7-CF914AF6B6EBQ31076682-4DFC8904-E616-46D6-8EDF-54DE31BE54ECQ33824506-84A2ED3F-4A74-44CA-9F1F-4FE931CD35EBQ33938075-E6B53FEC-FE6B-4327-81A8-8669E05C1025Q36011378-C93A47C9-014A-4841-ACD4-C455BA19E89EQ36593781-5DA6AD30-77AD-4967-9216-3178AA9E71B5Q37009066-057191DA-D4FB-4419-9552-0ED5E51DFC7CQ37351705-A9491F7D-511C-4BCF-BAA1-0734241E4534Q37428946-1B205508-FDFF-4B20-97AB-A6DF894B8A4CQ37889387-58D5EC99-871E-4E03-B635-233511F0DE4AQ37910256-C055C115-6C2A-4494-AEF6-8E5802F04349Q38210282-60F91AE4-76A4-40B1-813E-5EC12A9F89FCQ39701486-99F5E326-FF2F-4FAF-9559-444A7A7AA364Q41516902-209AEB74-57AC-4C0F-A8F1-F553086AD92EQ41860921-2761497D-C70A-4C3B-BE6B-D7F7F4710BA5Q42256356-70333DD8-A27F-4F5D-A9BC-F019E3C0795FQ43477934-2FD8CE8C-8219-412D-AC46-52A070C37549Q45198277-23706D18-9BEE-4EEA-A7C4-A2E39183FB72Q48238445-70B7A370-7D66-4349-A8C4-5788EC7284ADQ51150374-CE84D8DA-1CF2-4214-8F7E-57543178DE90
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Scedosporium species infections and treatments.
@ast
Scedosporium species infections and treatments.
@en
type
label
Scedosporium species infections and treatments.
@ast
Scedosporium species infections and treatments.
@en
prefLabel
Scedosporium species infections and treatments.
@ast
Scedosporium species infections and treatments.
@en
P2860
P1476
Scedosporium species infections and treatments.
@en
P2093
Perfect JR
Steinbach WJ
P2860
P356
10.1179/JOC.2003.15.SUPPLEMENT-2.16
P478
15 Suppl 2
P577
2003-11-01T00:00:00Z